Adagio Medical Holdings, Inc. (ADGM): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

-$20.92M
Year ended 2025-12-31
-$18.98M
Trailing 12 months to 2026-06-30
2023-12-31: -$27.41M2025-12-31: -$20.92M-$20.92M
2023-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31-$20.92Mn/a2026-03-27, From 2025-01-01
No annual figure between 2023-12-31 and 2025-12-31.
2023-12-31-$27.41Mn/a2025-03-27, From 2023-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
Adagio Medical Holdings, Inc. (ADGM)2025-12-31-$20.92Mn/a
Baxter International Inc (BAX)2025-12-31$673.00M-33.4%
Becton Dickinson & Co (BDX)2025-09-30$5.04B+7.6%
3M Co (MMM)2025-12-31$5.94B-4.0%
Teleflex Inc (TFX)2025-12-31$296.11M+11.7%
West Pharmaceutical Services Inc (WST)2025-12-31$756.30M+4.3%
Stryker Corp (SYK)2025-12-31$6.46B+26.3%
Haemonetics Corp (HAE)2026-03-28$268.45M-20.4%
KORU Medical Systems, Inc. (KRMD)2025-12-31-$2.16Mn/m

Compare ADGM, BAX, BDX, MMM side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗